S100B and perinatal asphyxia: S100B concentrations in the cerebrospinal fluid (CSF) were a reliable biomarker among neonates with perinatal asphyxia in the evaluation of brain lesion extent and correlated with the neurologic impairment at one year of age as well as with death before one year [10, 11].